© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
An interview with Dr. Jennifer K. Lue, Assistant Professor of Medicine, Center for Lymphoid Malignancies, Division of Hematology and Oncology, Columbia University Irving Medical Center
Treating CLL with CALQUENCE® (acalabrutinib)
July 28th 2021, 9:00pm
Although CLL follows a different staging format than other cancer types, diagnosing the disease properly can open the doors for more effective treatment and management strategies.
July 26th 2021, 1:00pm
About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.
July 22nd 2021, 6:00pm
More research is needed on how a chronic lymphocytic leukemia diagnosis can affect patients and their caregivers.
July 21st 2021, 6:00pm
TG-1701 monotherapy or added to ublituximab and Ukoniq contributed to early complete responses in patients with B-cell malignancies.
July 18th 2021, 9:00pm
Fixed-duration Venclexta plus Gazyva produced longer remissions than chemoimmunotherapy in elderly patients with chronic lymphocytic leukemia and other comorbidities.
June 16th 2021, 9:00pm
The combination of Imbruvica with Venclexta significantly reduced the risk for progression or death by 78% compared with chlorambucil plus obinutuzumab.
June 10th 2021, 1:00pm
Treatment with this combination was associated with encouraging clinical responses in this patient population.
June 8th 2021, 4:00pm
Although survival rates were similar, patients with chronic lymphocytic leukemia treated with Calquence experienced fewer side effects than those who received Imbruvica.
June 7th 2021, 9:00pm
Cirmtuzumab plus Imbruvica led to an 83.3% overall response rate, with 38.9% complete response and 44.4% partial response rate, in patients with mantle cell lymphoma and chronic lymphocytic leukemia.
April 28th 2021, 12:30pm
Don’t let your disease define you
Healthy Habits May Offset Genetic Cancer Risk
Expert Explains Prognosis Indicators, Treatment Plans in MCL
Smoking Cessation May Provide ‘Huge Benefit’ After Lung Cancer Diagnosis
The Game of Cancer